{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:08:20Z","timestamp":1763017700798},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/bmt.2016.280","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T15:32:02Z","timestamp":1477927922000},"page":"415-422","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The clinical value of biomarkers in respiratory complications in hematopoietic SCT"],"prefix":"10.1038","volume":"52","author":[{"given":"C M","family":"Lucena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gabarr\u00fas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Filella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"BFbmt2016280_CR1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617\u20131624.","journal-title":"JAMA"},{"key":"BFbmt2016280_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","volume":"7","author":"VT Ho","year":"2001","unstructured":"Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ . Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223\u2013229.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016280_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1658-3876(10)50025-6","volume":"3","author":"AO Soubani","year":"2010","unstructured":"Soubani AO, Pandya CM . The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther 2010; 3: 143\u2013157.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"BFbmt2016280_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2006-945530","volume":"27","author":"B Afessa","year":"2006","unstructured":"Afessa B, Peters SG . Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 2006; 27: 297\u2013309.","journal-title":"Semin Respir Crit Care Med"},{"key":"BFbmt2016280_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/bmt.2014.151","volume":"49","author":"CM Lucena","year":"2014","unstructured":"Lucena CM, Torres A, Rovira M, Marcos MA, de la Bellacasa JP, S\u00e1nchez M et al. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant 2014; 49: 1293\u20131299.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/thorax.56.5.379","volume":"56","author":"A Ra\u00f1\u00f3","year":"2001","unstructured":"Ra\u00f1\u00f3 A, Agust\u00ed C, Jimenez P, Angrill J, Benito N, Dan\u00e9s C et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001; 56: 379\u2013387.","journal-title":"Thorax"},{"key":"BFbmt2016280_CR7","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1378\/chest.108.5.1288","volume":"108","author":"RP Smith","year":"1995","unstructured":"Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH . A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288\u20131291.","journal-title":"Chest"},{"key":"BFbmt2016280_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","volume":"121","author":"JD Chalmers","year":"2008","unstructured":"Chalmers JD, Singanayagam A, Hill AT . C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219\u2013225.","journal-title":"Am J Med"},{"key":"BFbmt2016280_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00011-012-0439-5","volume":"61","author":"GN Matwivoff","year":"2012","unstructured":"Matwivoff GN, Prahl JD, Miller RJ, Carmichael JJ, Amundson DE, Seda G et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res 2012; 61: 401\u2013409.","journal-title":"Inflamm Res"},{"key":"BFbmt2016280_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-015-0792-1","volume":"19","author":"A Kutz","year":"2015","unstructured":"Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M et al. Prognostic value of procalcitonin in respiratory tract infections across clinical settings. Crit Care 2015; 19: 74.","journal-title":"Crit Care"},{"key":"BFbmt2016280_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jinf.2014.12.003","volume":"70","author":"PP Espa\u00f1a","year":"2015","unstructured":"Espa\u00f1a PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R et al. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. J Infect 2015; 70: 457\u2013466.","journal-title":"J Infect"},{"key":"BFbmt2016280_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/bmt.2012.193","volume":"48","author":"M Sato","year":"2013","unstructured":"Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K et al. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant 2013; 48: 698\u2013702.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00005-013-0228-z","volume":"61","author":"C Sj\u00f6qvist","year":"2013","unstructured":"Sj\u00f6qvist C, Snarski E . Inflammatory markers in patients after hematopoietic stem cell transplantation. Arch Immunol Ther Exp 2013; 61: 301\u2013307.","journal-title":"Arch Immunol Ther Exp"},{"key":"BFbmt2016280_CR14","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/sj.leu.2402946","volume":"17","author":"R Schots","year":"2003","unstructured":"Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003; 17: 1150\u20131156.","journal-title":"Leukemia"},{"key":"BFbmt2016280_CR15","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2169\/internalmedicine.50.5798","volume":"50","author":"Y Mori","year":"2011","unstructured":"Mori Y, Miyawaki K, Kato K, Takenaka K, Iwasaki H, Harada N et al. Diagnostic value of serum procalcitonin an C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Intern Med 2011; 50: 2149\u20132155.","journal-title":"Intern Med"},{"key":"BFbmt2016280_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis1029","volume":"56","author":"M AI Shuaibi","year":"2013","unstructured":"AI Shuaibi M, Bahu RR, Chaftari AM, AI Wohoush I, Shomali W, Jiang Y et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis 2013; 56: 943\u2013950.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016280_CR17","doi-asserted-by":"publisher","first-page":"E629","DOI":"10.1111\/j.1399-0012.2011.01495.x","volume":"25","author":"M Aguilar-Guisado","year":"2011","unstructured":"Aguilar-Guisado M, Jim\u00e9nez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A et al. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant 2011; 25: E629\u2013E638.","journal-title":"Clin Transplant"},{"key":"BFbmt2016280_CR18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/bmt.2012.18","volume":"47","author":"J Koya","year":"2012","unstructured":"Koya J, Nannya Y, Ichikawa M, Kurokawa M . The clinical role of procalcitonin in hematopoietic SCT. Bone Marrow Transplant 2012; 47: 1326\u20131331.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling Survival Data in Medical Research","author":"D Collett","year":"1994","unstructured":"Collett D . Modelling Survival Data in Medical Research. Chapman and Hall: London, UK, 1994."},{"key":"BFbmt2016280_CR20","first-page":"451","volume":"135","author":"M Christ-Crain","year":"2005","unstructured":"Christ-Crain M, M\u00fcller B . Procalcitonin in bacterial infections\u2014hype, hope, more or less? Swiss Med Wkly 2005; 135: 451\u2013460.","journal-title":"Swiss Med Wkly"},{"key":"BFbmt2016280_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1183\/09031936.00080411","volume":"39","author":"S Bello","year":"2012","unstructured":"Bello S, Lasierra AB, Minchol\u00e9 E, Fandos S, Ruiz MA, Vera E et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 2012; 39: 1144\u20131155.","journal-title":"Eur Respir J"},{"key":"BFbmt2016280_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s15010-008-7374-y","volume":"36","author":"Y Sakr","year":"2008","unstructured":"Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K . The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008; 36: 396\u2013407.","journal-title":"Infection"},{"key":"BFbmt2016280_CR23","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/320744","volume":"32","author":"EJ Giamarellos-Borboulis","year":"2001","unstructured":"Giamarellos-Borboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H . Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 1718\u20131725.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016280_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.0902-4441.2005.00568.x","volume":"76","author":"M Pihusch","year":"2006","unstructured":"Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76: 93\u2013101.","journal-title":"Eur J Haematol"},{"key":"BFbmt2016280_CR25","first-page":"643","volume":"87","author":"L Hambach","year":"2002","unstructured":"Hambach L, Eder M, Dammann E, Schrauder A, Sykora KW, Dieterich C et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643\u2013651.","journal-title":"Haematologica"},{"key":"BFbmt2016280_CR26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/CDLI.7.6.889-892.2000","volume":"7","author":"NM Blijlevens","year":"2000","unstructured":"Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE . Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000; 7: 889\u2013892.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFbmt2016280_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/thx.2004.030551","volume":"59","author":"C Agust\u00ed","year":"2004","unstructured":"Agust\u00ed C, Ra\u00f1\u00f3 A, Rovira M, Filella X, Benito N, Moreno A et al. Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients. Thorax 2004; 59: 1081\u20131088.","journal-title":"Thorax"},{"key":"BFbmt2016280_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/tid.12055","volume":"15","author":"YX Lyu","year":"2013","unstructured":"Lyu YX, Yu XC, Zhu MY . Comparison of the diagnostic value of procalcitonin and C-reactive protein after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transpl Infect Dis 2013; 15: 290\u2013299.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2016280_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/infdis\/jiv253","volume":"212","author":"DB Gilbert","year":"2015","unstructured":"Gilbert DB . Where do we go from here? J Infect Dis 2015; 212: 1687\u20131689.","journal-title":"J Infect Dis"},{"key":"BFbmt2016280_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/bmt.2014.296","volume":"50","author":"TR Spitzer","year":"2015","unstructured":"Spitzer TR . Engraftment syndrome: double-edged sword of hematopoietic cell transplants. Bone Marrow Transplant 2015; 50: 469\u2013475.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.bmt.1702517","volume":"26","author":"H Takatsuka","year":"2000","unstructured":"Takatsuka H, Takemoto Y, Yamada S, Wada H, Tamura S, Fujimori Y et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response s\u00edndrome. Bone Marrow Transplant 2000; 26: 419\u2013426.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","volume":"27","author":"TR Spitzer","year":"2001","unstructured":"Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893\u2013898.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.bbmt.2014.05.022","volume":"20","author":"L Chang","year":"2014","unstructured":"Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S et al. Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. Biol Blood Marrow Transplant 2014; 20: 1407\u20131417.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016280_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1164\/rccm.201410-1895ED","volume":"190","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Teixeira L . Sepsis biomarkers. Value and limitations. Am J Respir Crit Care Med 2014; 190: 1081\u20131082.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt2016280_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01740811","volume":"25","author":"W Karzai","year":"1997","unstructured":"Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K . Procalcitonin\u2013a new indicator of the systemic response to severe infections. Infection 1997; 25: 329\u2013334.","journal-title":"Infection"},{"key":"BFbmt2016280_CR36","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1210\/en.2003-0854","volume":"144","author":"P Linscheid","year":"2003","unstructured":"Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578\u20135584.","journal-title":"Endocrinology"},{"key":"BFbmt2016280_CR37","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1097\/CCM.0000000000000526","volume":"42","author":"L Debiane","year":"2014","unstructured":"Debiane L, Hachem RY, AI Wohoush I, Shomali W, Bahu RR, Jiang Y et al. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer. Crit Care Med 2014; 42: 2500\u20132507.","journal-title":"Crit Care Med"},{"key":"BFbmt2016280_CR38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/sj.bmt.1704045","volume":"31","author":"M Sauer","year":"2003","unstructured":"Sauer M, Tiede K, Fuchs D, Gruhn B, Berger D, Zintl F . Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003; 31: 1137\u20131142.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016280_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Habarth","year":"2001","unstructured":"Habarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396\u2013402.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016280","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:09:39Z","timestamp":1648062579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFbmt2016280"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.280","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"assertion":[{"value":"18 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}